An open trial of paroxetine in the treatment of children and adolescents diagnosed with dysthymia.

abstract：OBJECTIVES:The characterization and prediction of placebo response in clinical trials of youth with anxiety disorders have received little attention, despite the critical effects of placebo response rate on the success or failure of clinical trials. With this in mind, we sought to examine the factors that predict or in...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dobson ET,Strawn JR

更新日期：2016-10-01 00:00:00

abstract：OBJECTIVES:This study examines cardiovascular (CV) effects of guanfacine immediate-release (GUAN-IR), dexmethylphenidate extended-release (DMPH), and their combination (COMB) during acute and long-term treatment of youth with attention-deficit/hyperactivity disorder. METHODS:Two hundred seven participants aged 7-14 ye...

journal_title：Journal of child and adolescent psychopharmacology

authors： Sayer GR,McGough JJ,Levitt J,Cowen J,Sturm A,Castelo E,McCracken JT

更新日期：2016-12-01 00:00:00

abstract：: Objective: To guide clinicians in selecting the "next line" selective serotonin reuptake inhibitor (SSRI) for adolescents with treatment-resistant major depressive disorder, we sought to compare response rates among SSRIs in the Treatment of SSRI-Resistant Depression in Ad...

journal_title：Journal of child and adolescent psychopharmacology

authors： Strawn JR,Mills JA,Croarkin PE

更新日期：2019-05-01 00:00:00

abstract：PURPOSE:The aim of this study was to explore relationships between the Children's Depression Rating Scale-Revised (CDRS-R) and Hamilton Rating Scale for Depression (HAM-D) in adolescent bipolar disorder. We hypothesized that CDRS-R and HAM-D scores would be significantly correlated and both scales would be sensitive to...

journal_title：Journal of child and adolescent psychopharmacology

authors： Patel NC,DelBello MP,Kowatch RA,Strakowski SM

更新日期：2006-06-01 00:00:00

abstract：OBJECTIVE:Methylphenidate (MPH) is commonly used to treat attention-deficit/hyperactivity disorder (ADHD) in all children, including those with velocardiofacial syndrome (VCFS). Yet concerns have been raised regarding its safety and efficacy in VCFS. The goal of this study was to examine the safety and efficacy of MPH ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Green T,Weinberger R,Diamond A,Berant M,Hirschfeld L,Frisch A,Zarchi O,Weizman A,Gothelf D

更新日期：2011-12-01 00:00:00

abstract：:In the last 15 years, there has been a marked increase in the number of available stimulant formulations with the emphasis on long-acting formulations, and the introduction of several novel delivery systems such as orally dissolving tablets, chewable tablets, extended-release liquid formulations, transdermal patches, ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Steingard R,Taskiran S,Connor DF,Markowitz JS,Stein MA

更新日期：2019-06-01 00:00:00

abstract：:Although there are reports on their use for the treatment of enuresis, we present three pediatric cases with serotonin-selective reuptake inhibitor (SSRI)-induced enuresis. Because SSRIs continue to be commonly prescribed in the pediatric population, the need to monitor for the possibility of enuresis precipitated by ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Hergüner S,Kilinçaslan A,Görker I,Tüzün U

更新日期：2007-06-01 00:00:00

abstract：BACKGROUND:Weight gain due to the use of second-generation antipsychotics is a major health care issue for adult and paediatric psychiatric patients. Little is known about long-term weight gain effects of aripiprazole compared to risperidone in children and adolescents. OBJECTIVE:The primary aim of this study is to as...

journal_title：Journal of child and adolescent psychopharmacology

authors： Schoemakers RJ,van Kesteren C,van Rosmalen J,Eussen MLJM,Dieleman HG,Beex-Oosterhuis MM

更新日期：2019-04-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to describe the special considerations for building rapport and establishing a therapeutic alliance when conducting mental health evaluations for children and adolescents via videoconferencing. METHODS:The authors review the literature and describe their experience in conducting...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein F,Glueck D

更新日期：2016-04-01 00:00:00

abstract：OBJECTIVE:Patterns of benzodiazepine (BZD) use and long-term use among young adults are not well known. Our aim was to study trends in BZD use and long-term use among 18-25-year-old young adults by gender and active substance in a nationwide retrospective longitudinal register-based setting. METHODS:All Finns aged 18-...

journal_title：Journal of child and adolescent psychopharmacology

authors： Tähkäpää SM,Saastamoinen L,Airaksinen M,Tuulio-Henriksson A,Aalto-Setälä T,Kurko T

更新日期：2018-05-01 00:00:00

abstract：OBJECTIVE:In the four-site Treatment of Severe Childhood Aggression (TOSCA) study, addition of risperidone to stimulant and parent training moderately improved parent-rated disruptive behavior disorder (DBD) symptoms. This secondary study explores outcomes other than DBD and attention-deficit/hyperactivity disorder (AD...

journal_title：Journal of child and adolescent psychopharmacology

authors： Arnold LE,Gadow KD,Farmer CA,Findling RL,Bukstein O,Molina BS,Brown NV,Li X,Rundberg-Rivera EV,Bangalore S,Buchan-Page K,Hurt EA,Rice R,McNamara NK,Aman MG

更新日期：2015-04-01 00:00:00

abstract：:In the United States, the novel compound duloxetine has been approved for the treatment of major depressive disorder (MDD) and diabetic peripheral neuropathic pain in the adult population. There are currently no published data on the use of duloxetine in children and adolescents. This report describes the successful t...

journal_title：Journal of child and adolescent psychopharmacology

authors： Meighen KG

更新日期：2007-02-01 00:00:00

abstract：:ABSTRACT A report of neuroleptic malignant syndrome (NMS) in an adolescent patient with bipolar disorder is presented, and findings from a literature review of 35 child and adolescent cases (presenting before age 19) are compared with the reported experience in adults. Fever, rigidity, altered mental status, and tachy...

journal_title：Journal of child and adolescent psychopharmacology

authors： Steingard R,Khan A,Gonzalez A,Herzog DB

更新日期：1992-10-01 00:00:00

abstract：OBJECTIVE:This study examined the effects of pediatric anxiety and its interaction with gender on reward processes. Based on the purported greater sensitivity to risk in females than males and the propensity for risk aversion in anxiety, clinical anxiety and female gender were hypothesized to act synergistically in red...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dorfman J,Rosen D,Pine D,Ernst M

更新日期：2016-05-01 00:00:00

abstract：:The selective serotonin reuptake inhibitors (SSRIs) are becoming widely used in children and adolescents, with possible unexpected side effects being observed over time. SSRIs have been associated with bleeding in adults who have unremarkable routine hematologic laboratory results except abnormal bleeding time or plat...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lake MB,Birmaher B,Wassick S,Mathos K,Yelovich AK

更新日期：2000-04-01 00:00:00

abstract：:Self-report instruments commonly used to assess depression in adolescents have limited or unknown reliability and validity in this age group. We describe a new self-report scale, the Kutcher Adolescent Depression Scale (KADS), designed specifically to diagnose and assess the severity of adolescent depression. This rep...

journal_title：Journal of child and adolescent psychopharmacology

authors： LeBlanc JC,Almudevar A,Brooks SJ,Kutcher S

更新日期：2002-07-01 00:00:00

abstract：OBJECTIVE:Evening-dosed HLD200 is a delayed-release and extended-release methylphenidate (DR/ER-MPH) formulation consisting of uniform, dual-layered microbeads with an inner drug-loaded core. DR/ER-MPH is designed to delay the initial release of drug by 8-10 hours, and thereafter, provide a controlled, extended drug re...

journal_title：Journal of child and adolescent psychopharmacology

authors： Pliszka SR,Wilens TE,Bostrom S,Arnold VK,Marraffino A,Cutler AJ,López FA,DeSousa NJ,Sallee FR,Incledon B,Newcorn JH

更新日期：2017-08-01 00:00:00

abstract：BACKGROUND:Recent evidence indicates that atypical antipsychotics represent a promising option for the treatment of autistic disorder. In particular, risperidone appears to be effective in treating aggressiveness, hyperactivity, irritability, stereotypies, social withdrawal, and lack of interests. OBJECTIVE:The aim of...

journal_title：Journal of child and adolescent psychopharmacology

authors： Gagliano A,Germanò E,Pustorino G,Impallomeni C,D'Arrigo C,Calamoneri F,Spina E

更新日期：2004-04-01 00:00:00

abstract：OBJECTIVES:To evaluate the 52-week safety/tolerability of oral olanzapine for adolescents with schizophrenia or bipolar mania and compare effectiveness of a standard versus intense behavioral weight intervention in mitigating risk of weight gain. METHODS:Patients 13-17 years old with schizophrenia (Brief Psychiatric R...

journal_title：Journal of child and adolescent psychopharmacology

authors： Detke HC,DelBello MP,Landry J,Hoffmann VP,Heinloth A,Dittmann RW

更新日期：2016-12-01 00:00:00

abstract：OBJECTIVE:Few studies of psychotropic medication use among children and adolescents address the effectiveness of this medication, as it is typically used in naturalistic treatment settings. The objective of this study was to investigate psychotropic medication use among children and adolescents treated in system of car...

journal_title：Journal of child and adolescent psychopharmacology

authors： Drilea SK,Jowers K,Lichtenstein C,Hale M,Blau G,Stromberg S

更新日期：2013-02-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to investigate the link between the use of specific types of substances and suicidality in adolescent inpatients with schizophrenia and schizoaffective disorder. METHODS:We performed a 10-year naturalistic retrospective study of 178 adolescent inpatients diagnosed as suffering from ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Shoval G,Sever J,Sher L,Diller R,Apter A,Weizman A,Zalsman G

更新日期：2006-12-01 00:00:00

abstract：OBJECTIVE:The expanded use of antidepressants in youth has been the subject of numerous studies and some concerns in recent years. This study describes prescription patterns of antidepressants (ATD) for youths in Germany for the years 2000-2003 and includes prescription use of St. John's Wort. METHODS:Prescription dat...

journal_title：Journal of child and adolescent psychopharmacology

authors： Fegert JM,Kölch M,Zito JM,Glaeske G,Janhsen K

更新日期：2006-02-01 00:00:00

abstract：OBJECTIVE:The purpose of this trial was to investigate the short-term safety and efficacy of quetiapine fumarate in the treatment of children and adolescents with autistic disorder (AD). METHOD:This was a 16-week, open-label trial that included 6 male subjects with a mean age of 10.9 +/- 3.3 years. All subjects met th...

journal_title：Journal of child and adolescent psychopharmacology

authors： Martin A,Koenig K,Scahill L,Bregman J

更新日期：1999-01-01 00:00:00

abstract：OBJECTIVE:This study evaluates pediatric antidepressant prescribing practices of Nebraska clinicians. METHODS:Surveys were sent in July, 2005, to 1,521 prescribing clinicians throughout Nebraska to assess pediatric antidepressant use along with any practice changes following the U.S. Food and Drug Administration (FDA)...

journal_title：Journal of child and adolescent psychopharmacology

authors： Bhatia SK,Rezac AJ,Vitiello B,Sitorius MA,Buehler BA,Kratochvil CJ

更新日期：2008-02-01 00:00:00

abstract：:Bipolar disorder (BP) in youth is an impairing psychiatric disorder associated with high rates of relapse and recurrence. High rates of psychiatric and medical co-morbidities account for additional illness burden in pediatric BP. The elevated risk of overweight and obesity in this population is of particular concern. ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Goldstein TR,Goldstein BI,Mantz MB,Bailey B,Douaihy A

更新日期：2011-06-01 00:00:00

abstract：: Objective: Pediatric autoimmune neuropsychiatric disorder associated with Streptococcus pyogenes infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS) are emerging immune-mediated encephalopathies characterized by sudden onset of seemingly inexplica...

journal_title：Journal of child and adolescent psychopharmacology

authors： Lepri G,Rigante D,Bellando Randone S,Meini A,Ferrari A,Tarantino G,Cunningham MW,Falcini F

更新日期：2019-10-01 00:00:00

abstract：OBJECTIVE:The aim of this study was to summarize results of a blinded review of potential suicidal events and analyses comparing incidence rates between paroxetine- and placebo-treated pediatric patients. METHOD:One thousand one hundred ninety-one (1191) children and adolescents received paroxetine (n = 642) or placeb...

journal_title：Journal of child and adolescent psychopharmacology

authors： Apter A,Lipschitz A,Fong R,Carpenter DJ,Krulewicz S,Davies JT,Wilkinson C,Perera P,Metz A

更新日期：2006-02-01 00:00:00

abstract：OBJECTIVE:The purpose of this article was to examine whether injuries in early childhood and gender predict prescriptions of stimulant medication in three groups of children: With attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and other psychiatric disorders (OPD). METHODS:This was a ...

journal_title：Journal of child and adolescent psychopharmacology

authors： Dalsgaard S,Leckman JF,Nielsen HS,Simonsen M

更新日期：2014-06-01 00:00:00

abstract：OBJECTIVE:To evaluate measures of sleep (exploratory endpoints) in two pivotal studies of a multilayer bead extended-release methylphenidate (MPH-MLR) treatment of attention-deficit/hyperactivity disorder in children. METHODS:Study 1 evaluated the time course of response to MPH-MLR (n = 26) patients in an analog class...

journal_title：Journal of child and adolescent psychopharmacology

authors： Owens J,Weiss M,Nordbrock E,Mattingly G,Wigal S,Greenhill LL,Chang WW,Childress A,Kupper RJ,Adjei A

更新日期：2016-12-01 00:00:00

abstract：:The autism spectrum disorders (ASDs) can present with symptoms commonly found in mood and anxiety disorders. The Social Communication Questionnaire (SCQ), Children's Communication Checklist (CCC-2), and the Social Reciprocity Scale (SRS) were used to screen children in a mood disorders research clinic setting for symp...

journal_title：Journal of child and adolescent psychopharmacology

authors： Towbin KE,Pradella A,Gorrindo T,Pine DS,Leibenluft E

更新日期：2005-06-01 00:00:00